SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is driving intense community activity and speculative buying as traders anticipate a potential breakout and further price discovery. While some market participants express caution regarding volatility and project longevity, the active community remains focused on momentum and the potential for the stock to surpass previous highs.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as the community reacts to the announced preliminary design for the Phase 3 clinical trial of its lead candidate, CAD-1005, for Heparin-Induced Thrombocytopenia. Investors are actively debating the company's long-term clinical prospects versus concerns regarding ongoing cash burn and the potential for future equity offerings.

ProShares Trust - ProShares Ultra Semiconductors 2X Shares

ProShares Ultra Semiconductors

The ProShares Ultra Semiconductors ETF ($USD) is capturing significant investor attention as momentum in the semiconductor sector remains robust, with traders actively debating whether to scale into the fund to capitalize on the continued growth of high-performance AI hardware. Community sentiment is currently driven by the fund's leveraged exposure to industry leaders, leading to intense discussions regarding technical entry points, re-accumulation strategies during market volatility, and the fund's historical performance relative to broader technology-linked ETFs.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending on the back of a major $2.8 billion acquisition of the Serra Verde Group, a move widely discussed by the community as a strategic step toward building an end-to-end U.S. supply chain for critical magnets. Investors are closely monitoring the resulting volatility and share dilution implications, while technical analysts debate the sustainability of the recent breakout as interest in rare earth stocks remains heightened by ongoing geopolitical supply concerns.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors debate its long-term industrial value against ongoing volatility, fueled by active community discussion regarding a potential strategic partnership with POSCO and the company's role in the domestic infrastructure supply chain. Traders are closely monitoring the stock's technical support levels and high short interest, weighing the impact of fluctuating commodity prices and sector-specific catalysts against concerns over the company's debt profile and leadership.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors debate the company's massive cash hoard and its continued underperformance relative to broader market benchmarks. Community sentiment remains deeply divided, with some critics slamming management's lack of aggressive capital deployment into AI, while long-term supporters argue that the firm's defensive posture and pending leadership transition under Greg Abel offer stable value in a volatile market.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending due to a wave of high-value M&A activity and positive data readouts that are fueling optimism across the sector. Investors are actively discussing the potential for sector re-ratings, with many community members highlighting specific oncology and pipeline assets as undervalued opportunities for long-term growth.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market volatility driven by institutional accumulation and the ongoing expansion of its healthcare AI platform, highlighted by new strategic collaborations with major pharmaceutical partners like Gilead Sciences and Merck. Community discussion is heavily focused on the stock's potential for a major technical breakout or short squeeze, with long-term investors pointing to strong revenue growth and recurring partnerships as reasons to hold despite recent price fluctuations.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Elicio Therapeutics Inc.

Elicio Therapeutics Inc

Elicio Therapeutics is trending as investors focus on the company's progress with ELI-002, a cancer vaccine candidate targeting KRAS-mutant solid tumors, while discussing potential risks related to cash runway and future financing needs. Community sentiment remains split between excitement over strong preliminary clinical data and concerns regarding the necessity of capital raises or dilution to fund upcoming phase 3 trials.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle Mexican Grill is facing intense investor frustration as the stock struggles with downward pressure despite recent earnings efforts and expansion plans. The community is actively debating the effectiveness of current leadership and management strategies, frequently comparing the brand's lackluster performance and service quality to more agile competitors in the fast-casual sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
